Mef2btm2Rdf
Targeted Allele Detail
|
Symbol: |
Mef2btm2Rdf |
Name: |
myocyte enhancer factor 2B; targeted mutation 2, Riccardo Dalla-Favera |
MGI ID: |
MGI:6400973 |
Synonyms: |
Mef2bstopD83V |
Gene: |
Mef2b Location: Chr8:70605411-70620138 bp, + strand Genetic Position: Chr8, 34.15 cM, cytoband C1
|
Alliance: |
Mef2btm2Rdf page
|
|
Germline Transmission: |
Earliest citation of germline transmission:
J:265465
|
Parent Cell Line: |
Not Specified (ES Cell)
|
Strain of Origin: |
Not Specified
|
|
Allele Type: |
|
Targeted (Conditional ready, Humanized sequence, Null/knockout) |
Mutations: |
|
Insertion, Single point mutation
|
|
|
Mutation details: A loxP site flanked neomycin resistance gene and STOP cassette pair was inserted into intron 2. Exon 3 was replaced with a version containing a mutation that changes aspartic acid codon 83 into a valine codon (p.D83V). This creates a conditional-ready null allele that expresses the full mutated transcript only after cre-mediated removal of the neo and STOP cassettes.
(J:265465)
|
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
Carrying any Mef2b Mutation: |
22 strains or lines available
|
|
Original: |
J:265465 Brescia P, et al., MEF2B Instructs Germinal Center Development and Acts as an Oncogene in B Cell Lymphomagenesis. Cancer Cell. 2018 Sep 10;34(3):453-465.e9 |
All: |
1 reference(s) |
|